FDMT
4D Molecular Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$11.09+0.91%
Price as of Jul 20, 2026
FDMT analysis
4D Molecular Therapeutics, Inc. stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for FDMT is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research